Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First tricyclic oximino derivatives as 5-HT3 ligands.
Baglin I, Daveu C, Lancelot JC, Bureau R, Dauphin F, Pfeiffer B, Renard P, Delagrange P, Rault S. Baglin I, et al. Bioorg Med Chem Lett. 2001 Feb 26;11(4):453-7. doi: 10.1016/s0960-894x(00)00691-0. Bioorg Med Chem Lett. 2001. PMID: 11229746
New ursolic and betulinic derivatives as potential cytotoxic agents.
Baglin I, Poumaroux A, Nour M, Tan K, Mitaine-Offer AC, Lacaille-Dubois MA, Chauffert B, Cavé C. Baglin I, et al. J Enzyme Inhib Med Chem. 2003 Apr;18(2):111-7. doi: 10.1080/1475636031000093543. J Enzyme Inhib Med Chem. 2003. PMID: 12943194 Free article.
Secondary metabolites from lichen as potent inhibitors of advanced glycation end products and vasodilative agents.
Schinkovitz A, Le Pogam P, Derbré S, Roy-Vessieres E, Blanchard P, Thirumaran SL, Breard D, Aumond MC, Zehl M, Urban E, Kaur A, Jäger N, Hofer S, Kopp B, Stuppner H, Baglin I, Seraphin D, Tomasi S, Henrion D, Boustie J, Richomme P. Schinkovitz A, et al. Among authors: baglin i. Fitoterapia. 2018 Nov;131:182-188. doi: 10.1016/j.fitote.2018.10.015. Epub 2018 Oct 16. Fitoterapia. 2018. PMID: 30339926
[Engagement of students enrolled in fifth year of pharmacy studies in their academic or salaried pharmaceutical activities during the first period of lockout due to the COVID-19 pandemic (16th March-11th May 2020)].
Spiesser-Robelet L, Baglin I, Moal F, Lagarce F, Eveillard M. Spiesser-Robelet L, et al. Among authors: baglin i. Ann Pharm Fr. 2022 Jan;80(1):101-111. doi: 10.1016/j.pharma.2021.04.002. Epub 2021 Apr 14. Ann Pharm Fr. 2022. PMID: 33864805 Free PMC article. French.